Growing at an annualized rate of over 16.5%, the cell therapy manufacturing market / Roots Analysis

Mar 18, 2021

10 likes | 16 Vues

The approval of KYMIRAHu00ae, YESCARTAu00ae, Alofiselu00ae and Zyntelgou00ae has increased the interest of pharma stakeholders in cell therapies; further, owing to the technical challenges in this field, outsourcing manufacturing operations has become a necessity Roots Analysis has announced the addition of u201cCell Therapy Manufacturing Market (3rd Edition), 2019 - 2030u201d report to its list of offerings. Owing to various reasons, the demand for cell therapies is anticipated to increase over the coming years. Therefore, both therapy developers and contract service providers may need to strengthen their capabilities and expand available capacity. In this context, automation is expected to be a key enabler within the cell therapy manufacturing and contract services industry. To order this 550 page report, which features 160 figures and 250 tables, please visit this https://www.rootsanalysis.com/reports/view_document/cell-therapy-manufacturing/285.html

kevin987

Télécharger la présentation

Growing at an annualized rate of over 16.5%, the cell therapy manufacturing market / Roots Analysis

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

More Related